Viatris (VTRS) Reports Q3 Earnings: What Key Metrics Have to Say

For the quarter ended September 2025, Viatris (VTRS) reported revenue of $3.76 billion, up 0.2% over the same period last year. EPS came in at $0.67, compared to $0.75 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $3.65 billion, representing a surprise of +3.09%. The company delivered an EPS surprise of +6.35%, with the consensus EPS estimate being $0.63.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Viatris performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Net Sales- Developed Markets: $2.26 billion compared to the $2.2 billion average estimate based on three analysts. The reported number represents a change of -1.9% year over year.Net Sales- Greater China: $615.2 million versus the three-analyst average estimate of $578.59 million. The reported number represents a year-over-year change of +9.5%.Revenues- Other revenues: $12.4 million versus the three-analyst average estimate of $11.4 million. The reported number represents a year-over-year change of -6.1%.Net Sales- Emerging Markets: $570.4 million versus $549.78 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +7% change.Revenues- Total Net Sales: $3.75 billion compared to the $3.64 billion average estimate based on three analysts. The reported number represents a change of +0.3% year over year.Net Sales- JANZ: $306.3 million compared to the $302.56 million average estimate based on three analysts. The reported number represents a change of -11% year over year.View all Key Company Metrics for Viatris here>>>Shares of Viatris have returned +7.8% over the past month versus the Zacks S&P 500 composite's +1.3% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Viatris Inc. (VTRS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks